Headache theatre & meet the experts

H-. Lundbeck AS | Headache Theatre | 13:00–13:30

Speaker: Dr Stewart Tepper (Professor of Neurology, Geisel School of Medicine, Dartmouth and Vice President, New England Institute for Neurology and Headache, Stamford, Connecticut, USA)

AbbVie Inc. | Booth 5 | 10:15–10:45
Jana-Isabel Huhn-Doll, DE

AbbVie Inc. | Booth 5 | 15:45–16:15
Nirit Lev, Tel Aviv, IL

Eli Lilly and Company | Headache Theatre | 11:15–11:45

Speaker: Patricia Pozo-Rosich, MD is a neurologist and migraine specialist (Head of Neurology and Director of Migraine Adaptive Brain Center at Vall d’Hebron University Hospital, Assoc. Professor at University of Vic, Assoc. Clinical Professor at Dept of Medicine at University Autonoma of Barcelona)

Dr. Pozo-Rosich will discuss Emgality’s performance in real-world clinical settings with real patient cases and plenty of opportunities to ask questions and join the discussion.

AbbVie Inc. | Booth 5 | 11:15–11:45
Jana-Isabel Huhn-Doll, DE

Pfizer Inc. | Headache Theatre | 15:20–15:40

Speaker: Dr Stewart Tepper (Professor of Neurology, Geisel School of Medicine, Dartmouth and Vice President, New England Institute for Neurology and Headache, Stamford, Connecticut, USA)

Dr Stewart Tepper will summarise the pivotal clinical trial and safety data from an oral CGRP receptor antagonist that demonstrates a simple solution for different migraine needs.

H-. Lundbeck AS | Headache Theatre | 15:50–16:10

Speaker: Dr Stewart Tepper (Professor of Neurology, Geisel School of Medicine, Dartmouth and Vice President, New England Institute for Neurology and Headache, Stamford, Connecticut, USA)

AbbVie Inc. | Booth 5 | 11:15–11:45
Christina Tassorelli, Pavia, IT

Pfizer Inc. | Booth 4 | 15:20–15:40

Speaker: Professor Jelena Pavlovic (Headache Specialist, Montefiore Medical Center, and Assistant Professor of Neurology, Albert Einstein College of Medicine)

In this Meet the Expert session, Professor Jelena Pavlovic will present case studies exploring the burden and challenges faced by people living with migraine, and the need for different options for the acute treatment and prevention of migraine. This session will present data on an oral CGRP receptor antagonist and highlight patients that may be appropriate for such treatment.